Biogen Pharma (531752)
FAST GROWERScore breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1.4 |
| Market Cap | ₹92.89 Cr |
| P/E Ratio | 24.29 |
| ROCE | -0.39% |
| ROE | 4.5% |
| Dividend Yield | 0% |
| Profit Growth | 248.39% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹0.34 — ₹1.4 |
| Sector | Finance |
| Book Value | ₹0.65 |
Biogen Pharma trades with a P/E ratio of 24.29, ROCE of -0.39%, ROE of 4.5%, profit growth of 248.39%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer